Protein Sciences Corporation is a privately-held biotechnology company specializing in vaccine development and protein production. For over 25 years we have made it our mission to save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals. FluBlok®, its seasonal influenza vaccine, has shown exceptional performance in the clinic and is expected to receive U.S. FDA approval in 2011.
Protein Sciences Corporation was chosen as one of the 2011 Marcum Tech Top 40 fast growing companies.
Protein Sciences Corporation
Manon Cox, President & CEO